The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 6 November 2007, www.theannals.com, DOI 10.1345/aph.1K528.
 The Annals of Pharmacotherapy: Vol. 41, No. 12, pp. 2055-2057. DOI 10.1345/aph.1K528
© 2007 Harvey Whitney Books Company.
This Article
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in The Annals
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belloto, R. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belloto, R. J, Jr

On Statins, Strokes, Meta-Analyses, Competing Risks, and the Onward March of Science

Robert J Belloto Jr, BS Pharm PhD CGP FASCP

Staff Pharmacist, Department of Pharmacy, Good Samaritan Hospital, 2222 Philadelphia Dr., Dayton, OH 45406, fax 937/431-9048, Rbelloto{at}woh.rr.com

Reprints: Dr. Belloto

A comment on the conduct of a meta-analysis analyzing the effects of statins on cardiovascular and cerebrovascular outcomes is presented in this editorial. Competing risk and risk-stratified analysis models that may be more appropriate for the analysis of clinical trials in general and statin trials in particular are introduced. The avoidance of these more complicated models seems to be paradoxical when other models that clinicians have used for some time and are using today are seen to contain more patient variables than the proposed models. Certainly, one way these competing risk and general mathematical models will be used is to have the data readily available for other researchers to duplicate the calculations or use in entirely new ways. This aids in the learning process and helps students, reviewers, editors, and others who wish to research and judge the clinical trials.

Key Words: competing risks, meta-analysis, risk-stratified analysis, statins, stroke

Published Online, November 6, 2007. www.theannals.com, DOI 10.1345/aph.1K528

Related articles in The Annals:

Impact of Statins on Risk of Stroke: A Meta-Analysis
Nickole N Henyan, Daniel M Riche, Honey E East, and Pamela N Gann
The Annals 2007 41: 1937-1945. [Abstract] [Full Text]  





homecopy help contact us subscription past issues search current issue
Copyright © 2007 by Harvey Whitney Books Company.